3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow MediBeacon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring MB-102, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) - Kidney Diseases, Kidney Injury | Phase 3 | Completed | MediBeacon | 149 | 2023-03-20 | 2025-03-28 |
| A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants MB-102 DMID, MB-102 OMID, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) - Kidney Diseases, Kidney Injury | Phase 3 | Completed | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 121 | 2023-03-02 | 2024-01-02 |
| Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects MB-102, MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR) - Chronic Kidney Disease | Phase 3 | Completed | MediBeacon | 249 | 2022-06-14 | 2024-04-18 |
Kidney Diseases (2) · Renal Insufficiency (2) · Renal Insufficiency, Chronic (1)
relmapirazin (3)
China (2) · United States (2)
Dong Sun (1) · Richard B Dorshow, PhD (1) · Yanxia Yu (1) · Yuanyuan Luo (1)